Press Releases from Exactitude Consultancy (19541 total)
Spinal Muscular Atrophy (SMA) Market to Reach USD 13.1 Billion by 2034
Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disorder caused by mutations in the SMN1 gene, leading to insufficient survival motor neuron (SMN) protein.…
Tardive dyskinesia Market is expected to reach USD 8.2 billion by 2034
Tardive dyskinesia (TD) is a neurological movement disorder caused primarily by long-term use of dopamine receptor-blocking agents, such as antipsychotics and certain antiemetics. It is…
Transverse Myelitis Market is expected to reach USD 2.6 billion by 2034
Transverse myelitis (TM) is a rare neurological disorder caused by inflammation of the spinal cord, leading to motor, sensory, and autonomic dysfunction. Symptoms may include…
Tropical Spastic Paraparesis Market to Reach USD 1.3 Billion by 2034
Tropical spastic paraparesis (TSP), also known as HTLV-1-associated myelopathy (HAM/TSP), is a chronic, progressive neurological disorder caused by infection with the human T-cell lymphotropic virus…
Bipolar Disorder (Manic Depression) Market to Reach USD 14.8 Billion by 2034
Bipolar disorder, also known as manic depression, is a chronic psychiatric condition characterized by extreme mood swings, ranging from manic or hypomanic episodes to depressive…
Postoperative Pain Market is expected to reach USD 58.9 billion by 2034
Postoperative pain is one of the most common and challenging complications following surgery. Effective pain control is crucial for patient recovery, reduced hospital stays, and…
Dravet Syndrome (DS) market is expected to reach USD 1.9 billion by 2034
Dravet syndrome (DS) is a rare, severe, and lifelong form of epilepsy that typically begins in infancy. Characterized by prolonged seizures, developmental delays, motor impairments,…
Generalized Myasthenia Gravis (gMG) Market is expected to reach $9.8 billion by …
Generalized myasthenia gravis (gMG) is a rare, chronic autoimmune neuromuscular disorder characterized by muscle weakness, fatigue, and impaired communication between nerves and muscles. It is…
Lennox-Gastaut Syndrome (LGS) market is expected to reach USD 3.9 billion by 203 …
Lennox-Gastaut syndrome (LGS) is a severe, rare, childhood-onset epilepsy characterized by multiple seizure types, cognitive impairment, and resistance to standard antiepileptic drugs (AEDs). It accounts…
Neuromyelitis Optica Spectrum Disorder (NMOSD) Market to Reach USD 5.6 Billion b …
Neuromyelitis optica spectrum disorder (NMOSD) is a rare, chronic autoimmune disorder of the central nervous system primarily affecting the optic nerves and spinal cord, leading…
Spinocerebellar Ataxia (SCA) Market to Reach USD 2.1 Billion by 2034
Spinocerebellar ataxia (SCA) refers to a group of rare, inherited neurodegenerative disorders characterized by progressive loss of coordination, balance, and motor control due to cerebellar…
Alzheimer's Disease Market is expected to reach USD 17.2 billion by 2034
Alzheimer's disease (AD) is the most common cause of dementia, accounting for 60-70% of cases worldwide. It is a progressive neurodegenerative disorder characterized by memory…
Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis and Market Forecast 2024- …
Introduction
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants requiring prolonged mechanical ventilation or supplemental oxygen. It remains one of the…
Dementia with Lewy Bodies (DLB) Market is expected to reach 6.8 million by 2034
Dementia with Lewy bodies (DLB) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases worldwide. It…
Epilepsy Patient Pool Analysis Market to Reach 92 Million Patients by 2034
Epilepsy is one of the most common chronic neurological disorders, affecting more than 65 million people worldwide. Characterized by recurrent, unprovoked seizures due to abnormal…
Acute Ischemic Stroke (AIS) Market is expected to reach USD 17.5 billion by 2034
Acute ischemic stroke (AIS) is a life-threatening neurological emergency caused by the obstruction of blood flow to the brain, accounting for nearly 85% of all…
Brain Implants Market to Reach USD 13.6 Billion by 2034
Brain implants, also known as neuroprosthetics or neural implants, are medical devices placed directly into the brain to restore or enhance neurological function. These implants…
Cerebrospinal Fluid (CSF) Management Market is expected to reach USD 3.3 billion …
Cerebrospinal fluid (CSF) plays a vital role in protecting the brain and spinal cord, regulating intracranial pressure, and maintaining central nervous system homeostasis. Disorders such…
Flow Diverters Market is expected to reach USD 3.5 billion by 2034
Flow diverters are specialized endovascular stents designed to treat intracranial aneurysms, particularly wide-neck and large or giant aneurysms that are difficult to manage with traditional…
Intracranial Pressure (ICP) Monitoring Devices Market is expected to reach USD 3 …
Intracranial pressure (ICP) monitoring is a critical component in the management of patients with traumatic brain injury (TBI), intracerebral hemorrhage, hydrocephalus, stroke, brain tumors, and…
Spasticity Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Spasticity is a motor disorder characterized by involuntary muscle stiffness, spasms, and exaggerated reflexes caused by damage to the central nervous system (CNS). It frequently…
Secondary Progressive Multiple Sclerosis Market to Set Phenomenal Growth From 20 …
Introduction
Secondary progressive multiple sclerosis (SPMS) is a chronic and often disabling phase of multiple sclerosis (MS), where patients transition from the relapsing-remitting stage to a…
Primary Progressive Aphasia Market New Product Development & Latest Trends
Introduction
Primary progressive aphasia (PPA) is a rare neurodegenerative disorder characterized by the gradual loss of language abilities, including speaking, understanding, reading, and writing. Unlike other…
Partial Paralysis Market Growth, Applications, Innovations and Business Outlook …
Introduction
Partial paralysis, also known as paresis, is a condition characterized by the loss of voluntary muscle control in certain parts of the body due to…
Opioid Overdose Market Massive Growth opportunity Ahead
Introduction
Opioid overdose is a critical public health emergency, particularly in North America, where misuse of prescription opioids, fentanyl has fueled a devastating epidemic. According to…
Schizophrenia Market Growth, Applications, Innovations and Business Outlook by 2 …
Introduction
Schizophrenia is a chronic and severe psychiatric disorder that affects how a person thinks, feels, and behaves. Characterized by symptoms such as hallucinations, delusions, disorganized…
Precocious Puberty Market Detailed Industry Report Analysis 2025-2034
Introduction
Precocious puberty is a rare endocrine disorder where children experience the onset of puberty earlier than normal - typically before age 8 in girls and…
Postmenopausal Osteoporosis Market Massive Growth opportunity Ahead
Introduction
Postmenopausal osteoporosis is one of the most common metabolic bone disorders, characterized by reduced bone density and increased fracture risk due to declining estrogen levels…
Phosphoglucomutase 1 Deficiency Market Massive Growth opportunity Ahead
Phosphoglucomutase 1 Deficiency Market Outlook 2024-2034: Rare Disease Awareness, Genetic Testing, and Emerging Therapies Drive Growth
Introduction
Phosphoglucomutase 1 (PGM1) deficiency, also referred to as PGM1-CDG (congenital…
Maple Syrup Urine Disease (MSUD) Market Massive Growth opportunity Ahead
Introduction
Maple syrup urine disease (MSUD) is a rare, inherited metabolic disorder caused by a deficiency in the branched-chain. The condition is named after the characteristic…
Locally Advanced Pancreatic Cancer (LAPC) Market Growth, Applications, Innovatio …
Introduction
Pancreatic cancer remains one of the deadliest malignancies, with limited treatment options and poor survival outcomes. Locally advanced pancreatic cancer (LAPC) is an intermediate stage…
Diabetic Macular Edema Market Massive Growth opportunity Ahead
Introduction
Diabetic macular edema (DME) is one of the leading causes of vision impairment among people with diabetes, characterized by fluid leakage into the macula, the…
Cystinosis Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Cystinosis is a rare, inherited lysosomal storage disorder caused by the accumulation of cystine within cells, leading to progressive damage to multiple organs, including the…
Somatotropin Deficiency Market Growth, Applications, Innovations and Business Ou …
Introduction
Somatotropin deficiency, commonly referred to as growth hormone deficiency (GHD), is a rare endocrine disorder characterized by inadequate secretion of growth hormone (GH) from the…
Endogenous Cushing's Syndrome Market to Reach USD 1.9 Billion by 2034
Endogenous Cushing's Syndrome (CS) is a rare but serious endocrine disorder caused by chronic exposure to elevated cortisol levels due to the body's own overproduction.…
Secondary Hyperparathyroidism Market Growth, Trends, Consumer Demand and Key Opp …
Introduction
Secondary hyperparathyroidism (SHPT) is a frequent and serious complication of chronic kidney disease (CKD), characterized by excessive secretion of parathyroid hormone (PTH) due to impaired…
Familial Amyloid Polyneuropathy (FAP) Market to Reach USD 2.4 Billion by 2034
Familial Amyloid Polyneuropathy (FAP) is a progressive, inherited rare disease caused by mutations in the transthyretin (TTR) gene, leading to the buildup of misfolded amyloid…
Renal Insufficiency Market Insights and Future Outlook
Introduction
Renal insufficiency, also referred to as chronic kidney disease (CKD) or kidney function decline, is a progressive condition where the kidneys fail to filter blood…
Familial Lipoprotein Lipase Deficiency (LPLD) market is expected to reach USD 4. …
Familial Lipoprotein Lipase Deficiency (LPLD) is an ultra-rare, inherited metabolic disorder caused by mutations in the lipoprotein lipase (LPL) gene, which is responsible for breaking…
Goitre Market is expected to reach USD 4.5 billion by 2034
Goitre, an abnormal enlargement of the thyroid gland, is one of the most recognized thyroid disorders worldwide. It may result from iodine deficiency, autoimmune conditions…
Impaired Glucose Tolerance Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Impaired glucose tolerance (IGT) is a pre-diabetic state of hyperglycemia characterized by blood glucose levels that are higher than normal but not high enough to…
Underactive Bladder Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Underactive bladder (UAB) is a chronic, often underdiagnosed condition characterized by decreased detrusor muscle activity, leading to incomplete bladder emptying, infrequent urination, and urinary retention.…
Hereditary Hemochromatosis (HH) Market to Reach USD 5.1 Billion by 2034
Hereditary Hemochromatosis (HH) is a genetic disorder characterized by excessive absorption and storage of dietary iron, leading to iron overload in organs such as the…
Graves' Disease Market New Product Development & Latest Trends
Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overproduction of thyroid hormones, through antibodies that stimulate the thyroid gland. It is among the…
Heterozygous Familial Hypercholesterolemia (HeFH) Market to Reach USD 12 Billion …
Heterozygous Familial Hypercholesterolemia (HeFH) is a common yet underdiagnosed genetic disorder that significantly elevates low-density lipoprotein cholesterol (LDL-C) levels from birth. Affecting approximately 1 in…
Homocystinuria Market to Reach USD 1.5 Billion by 2034
Homocystinuria is a rare inherited metabolic disorder caused by a deficiency of enzymes involved in the metabolism of the amino acid methionine, most commonly cystathionine…
Primary Hyperoxaluria Market New Product Development & Latest Trends
Introduction
Primary hyperoxaluria (PH) is a group of rare, inherited metabolic disorders characterized by the overproduction of oxalate in the liver, leading to recurrent kidney stones,…
Hyperammonemia Market to Reach USD 2.5 Billion by 2034
Hyperammonemia is a metabolic condition characterized by abnormally elevated levels of ammonia in the blood, resulting from impaired detoxification in the liver or deficiencies in…
Hypertriglyceridemia Market is expected to reach USD 39 billion by 2034
Hypertriglyceridemia is a common lipid disorder characterized by elevated levels of triglycerides in the blood, often associated with obesity, diabetes, metabolic syndrome, and genetic predisposition.…
Hypoglycemia Market to Reach USD 2.5 Billion by 2034
Hypoglycemia, commonly defined as abnormally low blood glucose levels, is a serious condition that often affects individuals with diabetes receiving insulin or other glucose-lowering therapies.…
Go To Page: 11 12 13 14 15 16 17 18 19 20 181 182 183 184 185 186 187 188 189 190
